These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2552573)

  • 1. [PTH-like tumor peptide and malignant hypercalcemia].
    Rizzoli R; Bonjour JP
    Schweiz Med Wochenschr; 1989 Aug; 119(33):1099-105. PubMed ID: 2552573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of a parathyroid hormone analogue in the pathogenesis of malignant hypercalcemia].
    Rizzoli R; Buchs B; Pizurki L; Caverzasio J; Sappino AP; Vadas L; Arlot M; Bonjour JP
    Pathol Biol (Paris); 1990 Jun; 38(6):656-64. PubMed ID: 2197594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of bone and kidney in parathyroid hormone-related peptide-induced hypercalcemia in rats.
    Rizzoli R; Caverzasio J; Chapuy MC; Martin TJ; Bonjour JP
    J Bone Miner Res; 1989 Oct; 4(5):759-65. PubMed ID: 2554691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parathyroid hormone-related protein. A new calcium regulating hormone and its significance in tumor-associated hypercalcemia].
    Raue F; Blind E
    Dtsch Med Wochenschr; 1993 Jun; 118(24):916-20. PubMed ID: 8519211
    [No Abstract]   [Full Text] [Related]  

  • 5. [The pathogenesis of the humoral hypercalcemia syndrome in patients with solid tumors].
    Naafs MA; Silberbusch J
    Ned Tijdschr Geneeskd; 1989 May; 133(21):1065-9. PubMed ID: 2662028
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
    Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
    Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia of cancer: an update.
    Goni MH; Tolis G
    Anticancer Res; 1993; 13(4):1155-60. PubMed ID: 8352538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperparathyroidism, humoral hypercalcemia of malignancy, and the anabolic actions of parathyroid hormone and parathyroid hormone-related protein on the skeleton.
    Stewart AF
    J Bone Miner Res; 2002 May; 17(5):758-62. PubMed ID: 12009005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
    Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of postreceptor effects of 1-34 human hypercalcemia factor and 1-34 human parathyroid hormone in rat osteosarcoma cells.
    Rodan SB; Noda M; Wesolowski G; Rosenblatt M; Rodan GA
    J Clin Invest; 1988 Mar; 81(3):924-7. PubMed ID: 2830317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normocalcemic primary hyperparathyroidism: resistance to PTH effect on tubular reabsorption of calcium.
    Gardin JP; Paillard M
    Miner Electrolyte Metab; 1984; 10(5):301-8. PubMed ID: 6493158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of acute lymphoblastic leukemia accompanied with the production of parathyroid hormone-related protein.
    Harutsumi M; Akazai A; Kitamura T; Manki A; Tanaka H; Oda M; Seino Y
    Miner Electrolyte Metab; 1995; 21(1-3):171-6. PubMed ID: 7565443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiology and current management of cancer-related hypercalcemia.
    Warrell RP
    Oncology (Williston Park); 1992 Oct; 6(10):37-43; discussion 43, 47-50. PubMed ID: 1390013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone-related protein and transforming growth factor activities in an extract from a breast cancer associated with humoral hypercalcemia of malignancy.
    Nagata N; Yasutomo Y; Kugai N; Matsuura Y; Akatsu T; Sugiyama K; Kinoshita T; Takatani O; Mamiya Y; Yamaguchi K
    Jpn J Clin Oncol; 1989 Dec; 19(4):353-9. PubMed ID: 2558242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malignant hypercalcemia with and without bone metastasis].
    Millán Núñez-Cortés J; de Moneo González A
    Rev Clin Esp; 1996 Jun; 196(6):388-91. PubMed ID: 8767075
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy.
    Chattopadhyay N
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E761-70. PubMed ID: 16603723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral hypercalcemia of malignancy. The role of parathyroid hormone-related protein.
    Insogna KL
    Endocrinol Metab Clin North Am; 1989 Sep; 18(3):779-94. PubMed ID: 2673773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of the parathyrin-related protein (PTH-RP) in the diagnosis of cancer-associated hypercalcemia].
    Sagarra E; Villabona C; Bonnin R; Moliner R; Merino FJ; Sahún M; Soler J
    Med Clin (Barc); 1995 Oct; 105(12):450-4. PubMed ID: 7490935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.